Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

Morgan Stanley Lowers Medtronic to 'Equal-Weight'

Morgan Stanley downgraded Medtronic (MDT) to equal-weight.

Analyst Glenn Reicin says the medical products maker's third quarter revenues of $1.913 billion missed his estimates by just $2 million. He says one could argue that Medtronic deserves the extremely high valuation given the overall earnings environment. However, Reicin thinks the odds of continued multiple expansion is probably not that great near term.

He notes this is especially true when same-store growth is expected to moderate slightly later in the year. Reicin says given the limited upside, he thinks the equal-weight rating is appropriate. He sees $1.41 fiscal 2003 (April) earnings per share, and $1.62 for fiscal 2004. He has a $47 target.

blog comments powered by Disqus